albuterol has been researched along with Hyperplasia in 5 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In Colombia, compared with the use of albuterol alone, the use of beclomethasone dipropionate added to albuterol as needed for symptom relief is cost-effective in children 5 to 11 years old with mild intermittent (step 1) asthma, because it involves a higher probability of a lack of a requirement for prednisone for AE at lower total treatment costs." | 5.51 | As-Needed Use of Short-Acting β ( Buendia, JA; Rodríguez-Martínez, CE; Sossa-Briceño, MP, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodríguez-Martínez, CE | 1 |
| Sossa-Briceño, MP | 1 |
| Buendia, JA | 1 |
| Kramer, EL | 2 |
| Madala, SK | 1 |
| Hudock, KM | 1 |
| Davidson, C | 1 |
| Clancy, JP | 1 |
| Sauer, R | 1 |
| Griff, S | 1 |
| Blau, A | 1 |
| Franke, A | 1 |
| Mairinger, T | 1 |
| Grah, C | 1 |
| Mushaben, EM | 1 |
| Pastura, PA | 1 |
| Acciani, TH | 1 |
| Deutsch, GH | 1 |
| Khurana Hershey, GK | 1 |
| Korfhagen, TR | 1 |
| Hardie, WD | 1 |
| Whitsett, JA | 1 |
| Le Cras, TD | 1 |
| Kamachi, A | 1 |
| Munakata, M | 1 |
| Nasuhara, Y | 1 |
| Nishimura, M | 1 |
| Ohtsuka, Y | 1 |
| Amishima, M | 1 |
| Takahashi, T | 1 |
| Homma, Y | 1 |
| Kawakami, Y | 1 |
1 trial available for albuterol and Hyperplasia
| Article | Year |
|---|---|
As-Needed Use of Short-Acting β
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Albuterol; Anti-Asthmatic Agents; Asthma; Child | 2022 |
4 other studies available for albuterol and Hyperplasia
| Article | Year |
|---|---|
Subacute TGFβ Exposure Drives Airway Hyperresponsiveness in Cystic Fibrosis Mice through the PI3K Pathway.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Bronchoconstriction; Cystic Fibrosis; Goblet Cells; Hy | 2020 |
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia diagnosed by transbronchial lung cryobiopsy: a case report.
Topics: Aged; Albuterol; Anti-Inflammatory Agents; Biopsy; Bronchodilator Agents; Budesonide; Cough; Cryosur | 2017 |
Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice.
Topics: Airway Resistance; Albuterol; Animals; Bronchial Hyperreactivity; Cells, Cultured; Disease Models, A | 2009 |
Enhancement of goblet cell hyperplasia and airway hyperresponsiveness by salbutamol in a rat model of atopic asthma.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Anti-Inflammatory Agents; Asthma; Bronchoconstrictor A | 2001 |